Article
09 Apr 2026
Canada's Dormant DIN Problem: How Marketing Status Is Undermining Pharmaceutical IP Protections Under CUSMA
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in Canada
AUTHORS CONTENT
Article
19 Mar 2026
Le CEPMB lance une consultation sur le projet de directives relatives à la pratique pour les audiences
Article
17 Mar 2026
PMPRB Launches Consultation On Proposed Practice Directions For Hearings
Article
29 Dec 2025
Les lignes directrices définitives du CEPMB sur le prix des médicaments brevetés entrent en vigueur le 1er janvier 2026 : ce que cela signifie pour les entreprises pharmaceutiques innovantes
Article
23 Dec 2025
Final Patented Medicines Pricing Guidelines From The PMPRB Take Effect On January 1, 2026: What This Means For Innovative Pharma
Article
21 Nov 2025
Dealing A New Hand: Federal Court Gives Card Game Patent A Second Chance
Article
28 Oct 2025
What The Frack? FCA Clarifies Claim Construction And Double Patenting